Peter Galle
Peter Galle
Professor für Medizin, Mainz University
Verified email at
Cited by
Cited by
Sorafenib in advanced hepatocellular carcinoma
JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ...
New England journal of medicine 359 (4), 378-390, 2008
EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
Journal of hepatology 56 (4), 908-943, 2012
Simplified criteria for the diagnosis of autoimmune hepatitis
EM Hennes, M Zeniya, AJ Czaja, A Parés, GN Dalekos, EL Krawitt, ...
Hepatology 48 (1), 169-176, 2008
Cutting edge: TGF-β induces a regulatory phenotype in CD4+ CD25− T cells through Foxp3 induction and down-regulation of Smad7
MC Fantini, C Becker, G Monteleone, F Pallone, PR Galle, MF Neurath
The Journal of Immunology 172 (9), 5149-5153, 2004
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis …
R Atreya, J Mudter, S Finotto, J Müllberg, T Jostock, S Wirtz, M Schütz, ...
Nature medicine 6 (5), 583-588, 2000
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
RS Finn, S Qin, M Ikeda, PR Galle, M Ducreux, TY Kim, M Kudo, V Breder, ...
New England Journal of Medicine 382 (20), 1894-1905, 2020
Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells—A mechanism of immune evasion?
S Strand, WJ Hofmann, H Hug, M Müller, G Otto, D Strand, SM Mariani, ...
Nature medicine 2 (12), 1361-1366, 1996
Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo
R Kiesslich, J Burg, M Vieth, J Gnaendiger, M Enders, P Delaney, ...
Gastroenterology 127 (3), 706-713, 2004
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
M Müller, S Wilder, D Bannasch, D Israeli, K Lehlbach, M Li-Weber, ...
The Journal of experimental medicine 188 (11), 2033-2045, 1998
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
J Bridgewater, PR Galle, SA Khan, JM Llovet, JW Park, T Patel, TM Pawlik, ...
Journal of hepatology 60 (6), 1268-1289, 2014
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
R Kiesslich, J Fritsch, M Holtmann, HH Koehler, M Stolte, S Kanzler, ...
Gastroenterology 124 (4), 880-888, 2003
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
PR Galle, WJ Hofmann, H Walczak, H Schaller, G Otto, W Stremmel, ...
The Journal of experimental medicine 182 (5), 1223-1230, 1995
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.
M Müller, S Strand, H Hug, EM Heinemann, H Walczak, WJ Hofmann, ...
The Journal of clinical investigation 99 (3), 403-413, 1997
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
I Tiede, G Fritz, S Strand, D Poppe, R Dvorsky, D Strand, HA Lehr, S Wirtz, ...
The Journal of clinical investigation 111 (8), 1133-1145, 2003
Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet
S Finotto, MF Neurath, JN Glickman, S Qin, HA Lehr, FHY Green, ...
Science 295 (5553), 336-338, 2002
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker, MC Fantini, C Schramm, HA Lehr, S Wirtz, A Nikolaev, J Burg, ...
Immunity 21 (4), 491-501, 2004
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...
Gastroenterology 150 (5), 1147-1159. e5, 2016
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial
J Bruix, JL Raoul, M Sherman, V Mazzaferro, L Bolondi, A Craxi, PR Galle, ...
Journal of hepatology 57 (4), 821-829, 2012
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease
MF Neurath, B Weigmann, S Finotto, J Glickman, E Nieuwenhuis, H Iijima, ...
The Journal of experimental medicine 195 (9), 1129-1143, 2002
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo …
AX Zhu, YK Kang, CJ Yen, RS Finn, PR Galle, JM Llovet, E Assenat, ...
The lancet oncology 20 (2), 282-296, 2019
The system can't perform the operation now. Try again later.
Articles 1–20